New bifunctional Prodrugs with cleavable linker for targeted tumor therapy (ADC)

Scientists at the University of Göttingen in Germany developed new and highly potent drugs with cleavable chemical linkers to develop tumor specific antibodies for selective tumor therapy (ADC). The soluble prodrugs are activated into highly cytotoxic drugs only in targeted tumor cells.

Further information: PDF

MBM ScienceBridge GmbH
Phone: (0551) 30724-151

Contact
Dr. Jens-Peter Horst

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Boulder detection for monopile foundations

…and submarine cables in the Baltic Sea for Baltic Power Offshore Wind Farm. The Fraunhofer Institute for Wind Energy Systems IWES has conducted a boulder detection campaign in the Baltic…

Artificial Intelligence for Improved Baltic Sea Protection

Innovative Monitoring Concept for the Eckernförde Bay Receives State Funding. Artificial intelligence will help improve the monitoring of the ecological condition of the Eckernförde Bay in the future. The linking…

New findings on the immune system

Underlying mechanism for the development of T follicular helper cells deciphered. T follicular helper cells (Tfh) are essential for strong antibody-mediated reactions of our immune system during infections and vaccinations….

Partners & Sponsors